Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.
Albert Labs has raised $605K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2023.
Albert Labs's investors include Cantheon Capital.
Albert Labs is headquartered in Vancouver, Canada.
Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.
Albert Labs is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Albert Labs — Funding & Investors." VCBacked, March 23, 2023, https://www.vcbacked.co/company/albert-labs. Accessed August 14, 2026.
VCBacked. (2023). Albert Labs — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/albert-labs
{{cite web |title=Albert Labs — Funding & Investors |url=https://www.vcbacked.co/company/albert-labs |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated